Therefore, these findings established the Adnp-haploinsufficient mouse as a valid model for the human ADNP syndrome patient and provided a solid basis for the further clinical development of NAP (CP201) in children suffering from the ADNP syndrome (Hacohen-Kleiman et al., 2018). The gene discussed is ADNP; the disease is ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder.